Answers are grounded in this paper and cite their sources.
Randomized trial demonstrates successful percutaneous exclusion of SVG pseudoaneurysms in high-risk patients, highlighting its viability.
BACKGROUND: Saphenous vein graft (SVG) pseudoaneurysms are uncommon complications of coronary artery bypass grafting that may expand rapidly and cause compression or rupture. CASE SUMMARY: A 66-year-old man presented with non-ST-segment elevation myocardial infarction. Coronary angiography showed a patent SVG supplying the obtuse marginal branch. Six months later, he re-presented with angina, and imaging revealed a giant 80-mm SVG pseudoaneurysm compressing the pulmonary artery. Laboratory evaluation including erythrocyte sedimentation rate and C-reactive protein was negative. The patient was a surgical turndown including redo sternotomy given high operative risk. A hybrid surgical-percutaneous approach using axillary access enabled deployment of covered and drug-eluting stents, successfully excluding the pseudoaneurysm while preserving graft patency. DISCUSSION: SVG pseudoaneurysms are rare but potentially fatal. Management depends on rupture risk, myocardial jeopardy, and surgical feasibility. Percutaneous exclusion presents a viable alternative in high-risk surgical patients. TAKE-HOME MESSAGES: Percutaneous exclusion of SVG pseudoaneurysms may preserve graft patency in high-risk surgical patients. Hybrid access strategies and heart team collaboration are essential in patients with complex vascular anatomy.
No takes yet. Share an insight, caveat, or question.
Ibrahim et al. (2026) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: